Related to Companion Dx Negotiates License to Epigenomics’ Septin9 Blood Biomarker for CRC Test

• Mechanism for Gene Silencing in Skin Cancer Discovered
  
• MethylGene and Pharmion Ink $101M Expansion to Cancer Alliance
  
• Gene Methylation Holds Prognostic Value for Liver Cancer Patients
  
• Scientists Develop Test for Early Detection of HCC
  
• OncoMethylome Sciences Inks Biomarker Development Deal with GSK
  
• DNA Methylation Found to Change over Time
  
• Study of Glioblastoma Multiforme Implicates New Genes and Suggests a Theory for Chemotherapy Resistance
  
• Vast Majority of DNA Methylation Sites Found on Regions Near Islands
  
• Scientists Able to Reprogram Human Embryos Using Human Eggs but Not Animal Eggs
  
• Prognostic Biomarker for Colorectal Cancer Found in Lymph Node
  
• Gene Involved in Energy Consumption Is Epigenetically Modified in Type 2 Diabetics
  
• Einstein Obtains $3.5M to Study Epigenomics of Abnormal Fetal Growth and Chronic Kidney Disease
  
• Epigenomics Provides CE-Marked IVD Blood Test for Colorectal Cancer
  
• Researchers Explain How Tobacco Carcinogen NNK Triggers Lung Tumors
  
• Investigators Come Up with Virus-Free Technique to Make Stem Cells Pluripotent
  
• Researchers Uncover Mechanism of Tobacco Carcinogen
  
• Life Technologies Introduces Nanocrystal-Based Single Molecule Sequencing Technology
  
• ExonHit and bioMérieux Scrap Colorectal Cancer from Biomarker Discovery Program
  
• IntegraGen Becomes First French Service Provider of Illumina Tools
  
• Broad Institute Buys Another 30 Genome Analyzers from Illumina